- New information about hypoglycemia and medications for type 2 diabetes are the first online revisions to the American Diabetes Association’s (ADA's) Standards of Medical Care in Diabetes, which were previously only updated annually.
Why this matters
- The diabetes field advances rapidly.
2 new updates to 2018 ADA Standards
- A revised definition of hypoglycemia in sections 6 and 14: both sections on glycemic targets and on diabetes care in the hospital have been updated to align with the new 3-level hypoglycemia categorization from a consensus report of ADA and other diabetes-related organizations, published in December 2017 in Diabetes Care.
- 2 new drugs added to section 8: the glucagon-like peptide-1 agonist semaglutide (Ozempic) and the sodium-glucose cotransporter 2 inhibitor ertugliflozin (Steglatro) have been added to the section on pharmacologic approaches to glycemic treatment, after their approval by the FDA in December 2017.